Physician profile
John Hardeman
NPI 1558598771
$389.99
in general payments reported to CMS, 2019-2025
12 companies · $73.52 in 2025
The $73.52 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.43 · 2020: $63.58 · 2021: $20.95 · 2022: $97.01 · 2023: $38.11 · 2024: $37.39 · 2025: $73.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $59.57 | 2022 | |
| Merck Sharp & Dohme LLC | $50.70 | 2019-2020 | |
| Biocomposites INC | $38.76 | 2025 | Stimulan |
| Organon LLC | $38.16 | 2022-2024 | |
| Pfizer INC. | $38.11 | 2023 | |
| Coopersurgical, INC. | $36.75 | 2019-2020 | |
| Evofem Biosciences, INC. | $36.67 | 2022-2024 | |
| Medtronic, INC. | $34.76 | 2025 | Plasmablade(Tm) |
| Alydia Health | $20.95 | 2021 | |
| Abbvie INC. | $13.40 | 2019 | |
| Lupin INC. | $11.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hardeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.